What is Fertility Focus?
Fertility Focus is dedicated to empowering women by enhancing their understanding and control over their reproductive cycles. The company has developed the OvuSense fertility monitoring family, designed to improve the chances of successful pregnancy. Its flagship products, OvuCore and OvuSense® Pro, offer advanced ovulation prediction and detection with high accuracy, outperforming traditional methods. The recent launch of OvuFirst, a patented skin temperature sensor, provides a convenient and accurate way for women to track their cycles and identify their fertile windows early. Fertility Focus also actively supports the community through its 'PCOS Fertility Support Group' on Facebook, demonstrating a holistic approach to fertility care.
How much funding has Fertility Focus raised?
Fertility Focus has raised a total of $2.7M across 1 funding round:
Series A
$2.7M
Series A (2019): $2.7M with participation from Foresight Group LLP and Coutts Investment Club
Key Investors in Fertility Focus
Foresight Group LLP
Foresight Group LLP is a prominent independent investment manager specializing in infrastructure and private equity, founded in 1984 and headquartered in London.
Coutts Investment Club
Coutts is a historic London-based private bank and wealth management firm, established in 1692, offering a comprehensive suite of financial services.
What's next for Fertility Focus?
With this substantial enterprise-level backing, Fertility Focus is poised for significant expansion. The strategic investment will likely fuel further research and development into new fertility technologies, potentially broadening their product line to encompass more stages of a woman's fertility journey. Expansion into new markets and enhancement of existing product capabilities are also probable strategic objectives. The company's focus on data-driven insights and community support positions it for continued leadership in the femtech sector.
See full Fertility Focus company page
